Sheth U, Oijerstedt L, Heckman M, White L, Heuer H, Lario Lago A
Mol Neurodegener. 2025; 20(1):30.
PMID: 40075459
PMC: 11905702.
DOI: 10.1186/s13024-025-00821-4.
Mondesert E, Delaby C, De La Cruz E, Kuhle J, Benkert P, Pradeilles N
Neurology. 2025; 104(6):e213400.
PMID: 40009787
PMC: 11863781.
DOI: 10.1212/WNL.0000000000213400.
Yun J, Shin D, Lee E, Kim J, Ham H, Gu Y
JAMA Neurol. 2025; .
PMID: 39960728
PMC: 11833660.
DOI: 10.1001/jamaneurol.2024.5263.
Bluma M, Chiotis K, Bucci M, Savitcheva I, Matton A, Kivipelto M
EBioMedicine. 2024; 112:105504.
PMID: 39701863
PMC: 11873569.
DOI: 10.1016/j.ebiom.2024.105504.
Yan Z, Gu Q, Yin H, Yi M, Wang X, Sun R
Eat Weight Disord. 2024; 29(1):76.
PMID: 39612146
PMC: 11607027.
DOI: 10.1007/s40519-024-01706-z.
Temporal Dynamics of Plasma Neurofilament Light in Blood Donors With Preclinical Multiple Sclerosis.
Britze J, Larsen M, Pedersen A, Rosthoj S, Bach Sondergaard H, Magyari M
Neurol Neuroimmunol Neuroinflamm. 2024; 12(1):e200335.
PMID: 39602675
PMC: 11616971.
DOI: 10.1212/NXI.0000000000200335.
Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer's disease.
Hofmann A, Hasler L, Lambert M, Kaeser S, Graber-Sultan S, Obermuller U
Nat Commun. 2024; 15(1):9982.
PMID: 39557867
PMC: 11574007.
DOI: 10.1038/s41467-024-52937-8.
Plasma Alzheimer's disease biomarker variability: Amyloid-independent and amyloid-dependent factors.
Lee E, Kang S, Shin D, Kim Y, Zetterberg H, Blennow K
Alzheimers Dement. 2024; 21(1):e14368.
PMID: 39535473
PMC: 11782842.
DOI: 10.1002/alz.14368.
Serum neurofilament light chain: a novel biomarker for cardiovascular diseases in individuals without hypertension.
Liu J, Zhang Y
Sci Rep. 2024; 14(1):26117.
PMID: 39478121
PMC: 11526128.
DOI: 10.1038/s41598-024-77446-y.
Blood-Based Biomarkers in Alzheimer's Disease: Advancing Non-Invasive Diagnostics and Prognostics.
Dhauria M, Mondal R, Deb S, Shome G, Chowdhury D, Sarkar S
Int J Mol Sci. 2024; 25(20).
PMID: 39456697
PMC: 11507237.
DOI: 10.3390/ijms252010911.
Plasma neurofilament light chain as prognostic marker of cognitive decline in neurodegenerative diseases, a clinical setting study.
Gotze K, Vrillon A, Dumurgier J, Indart S, Sanchez-Ortiz M, Slimi H
Alzheimers Res Ther. 2024; 16(1):231.
PMID: 39427171
PMC: 11490051.
DOI: 10.1186/s13195-024-01593-7.
Plasma Biomarkers of Alzheimer's Disease and Neurodegeneration According to Sociodemographic Characteristics and Chronic Health Conditions.
Zheng H, Wu Z, Mielke M, Murray A, Ryan J
J Prev Alzheimers Dis. 2024; 11(5):1189-1197.
PMID: 39350363
PMC: 11436401.
DOI: 10.14283/jpad.2024.142.
Neurofilament Light Chain as Biomarker in Encephalitis.
Wellmann S, Geis T, Kuhle J, Lehnerer V
J Clin Med. 2024; 13(18).
PMID: 39336905
PMC: 11432516.
DOI: 10.3390/jcm13185416.
Renal function's impact on serum neurofilament levels in patients with multiple sclerosis: an exploratory analysis.
Tortosa-Carreres J, Cubas-Nunez L, Sanz M, Castillo-Villalba J, Gasque-Rubio R, Carratala-Bosca S
Neurol Sci. 2024; 46(2):845-853.
PMID: 39307881
DOI: 10.1007/s10072-024-07772-6.
Impact of amyloid and cardiometabolic risk factors on prognostic capacity of plasma neurofilament light chain for neurodegeneration.
Kim K, Kim E, Lee J
Alzheimers Res Ther. 2024; 16(1):202.
PMID: 39267169
PMC: 11397040.
DOI: 10.1186/s13195-024-01564-y.
Neurofilament light chain as a diagnostic and prognostic biomarker in Guillain-Barré syndrome.
Hafsteinsdottir B, Farman H, Lagerstrom N, Zetterberg H, Andersen O, Novakova L
J Neurol. 2024; 271(11):7282-7293.
PMID: 39249104
PMC: 11561089.
DOI: 10.1007/s00415-024-12679-5.
Navigating the Landscape of Plasma Biomarkers in Alzheimer's Disease: Focus on Past, Present, and Future Clinical Applications.
Ankeny S, Bacci J, Decourt B, Sabbagh M, Mielke M
Neurol Ther. 2024; 13(6):1541-1557.
PMID: 39244522
PMC: 11541985.
DOI: 10.1007/s40120-024-00658-x.
Association between systemic immune-inflammation index and serum neurofilament light chain: a population-based study from the NHANES (2013-2014).
Liu X, Yang Y, Lu Q, Yang J, Yuan J, Hu J
Front Neurol. 2024; 15:1432401.
PMID: 39239395
PMC: 11374650.
DOI: 10.3389/fneur.2024.1432401.
Glial fibrillary acidic protein and neurofilament light chain as biomarkers in pediatric multiple sclerosis.
Saucier L, Healy B, Saxena S, Sanon E, Chitnis T
Mult Scler J Exp Transl Clin. 2024; 10(3):20552173241274567.
PMID: 39193071
PMC: 11348348.
DOI: 10.1177/20552173241274567.
Trajectories of behavior and social cognition in behavioral variant frontotemporal dementia and primary psychiatric disorders: A call for better operationalization of socioemotional changes.
Fieldhouse J, van Engelen M, Handgraaf D, de Boer S, van t Hooft J, Schouws S
Eur J Neurol. 2024; 31(12):e16426.
PMID: 39171655
PMC: 11555130.
DOI: 10.1111/ene.16426.